Difficulty: Medium
Average Score: 93%
Practice
Enzyme drug used for acute leukemia treatment:
Correct answer
B
Rationale
In the treatment of acute leukemia, the enzyme drug used is Asparaginase. Asparaginase works by depleting levels of asparagine in the blood, which is essential for leukemia cells to grow and survive. By depriving the cancer cells of this vital amino acid, their growth is inhibited, leading to cell death.
Option A, Dihydrofolate reductase, is not the correct answer because it is an enzyme targeted by drugs like methotrexate for the treatment of various cancers and autoimmune diseases, not specifically acute leukemia.
Option C, Aromatase, is an enzyme targeted in hormone-positive breast cancer treatment to inhibit estrogen production, and it is not used in acute leukemia therapy.
Option D, DNA gyrase, is an enzyme targeted by antibiotics like fluoroquinolones to inhibit bacterial DNA replication, and it is not relevant to the treatment of acute leukemia.
Understanding the mechanism of action of each drug is crucial for healthcare professionals to make informed decisions in patient care. In the context of pharmacology across the lifespan, knowing the appropriate enzyme drug for specific conditions is essential for providing safe and effective treatment, especially in vulnerable populations like pediatric patients with acute leukemia.
Option A, Dihydrofolate reductase, is not the correct answer because it is an enzyme targeted by drugs like methotrexate for the treatment of various cancers and autoimmune diseases, not specifically acute leukemia.
Option C, Aromatase, is an enzyme targeted in hormone-positive breast cancer treatment to inhibit estrogen production, and it is not used in acute leukemia therapy.
Option D, DNA gyrase, is an enzyme targeted by antibiotics like fluoroquinolones to inhibit bacterial DNA replication, and it is not relevant to the treatment of acute leukemia.
Understanding the mechanism of action of each drug is crucial for healthcare professionals to make informed decisions in patient care. In the context of pharmacology across the lifespan, knowing the appropriate enzyme drug for specific conditions is essential for providing safe and effective treatment, especially in vulnerable populations like pediatric patients with acute leukemia.